Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

ASML Shares Target €1,000 Milestone Following Major Upgrade

Andreas Sommer by Andreas Sommer
November 27, 2025
in Analysis, European Markets, Semiconductors
0
ASML Stock
0
SHARES
28
VIEWS
Share on FacebookShare on Twitter

A significant vote of confidence has revitalized sentiment toward Dutch chip equipment manufacturer ASML. After a period of market uncertainty and mixed quarterly results, the investment bank Morgan Stanley has not only upgraded the company but has also designated it as the premier investment choice, or “Top Pick,” within the entire European semiconductor sector. With US markets closed for a holiday, European investors are now questioning whether this marks the beginning of a new rally toward record highs.

Market Sentiment Shifts Following Quarterly Report

This optimistic shift provides a welcome relief for investors. The market responded enthusiastically on Wednesday, with shares surging over 5% in Amsterdam and reclaiming the psychologically significant €900 level. The momentum continued into Thursday, with the stock consolidating around €898.00.

This change in atmosphere is crucial, coming after the third-quarter report in October delivered somewhat disappointing news. While earnings per share exceeded expectations, revenue that fell slightly short of forecasts had raised doubts about the company’s growth trajectory. These concerns now appear to be receding, bolstered by a positive gross margin projection of 52.3% for 2026.

Analyst Report Fuels Optimism

The catalyst for this renewed euphoria is a fresh analysis from Morgan Stanley, which has brought the stock into sharp focus. Analyst Lee Simpson believes the optimal entry point has arrived, arguing that the wait for more favorable share prices is over. Consequently, he raised the price target from €975 to a round €1,000.

Should investors sell immediately? Or is it worth buying ASML?

The message is unambiguous: the bank anticipates a significant recovery for the 2026 fiscal year. Following recent share price weakness, the equity is now seen as attractively valued, creating immediate buying pressure in the market.

Key Growth Drivers: AI and Memory Chips

What underpins this sudden wave of optimism? Morgan Stanley has identified two primary, powerful drivers expected to propel ASML’s business:

  • The ongoing AI boom: Unabated demand for Nvidia’s Blackwell chips is filling order books across the semiconductor industry. This is compelling chip manufacturers to accelerate their capacity expansions, a situation that directly benefits the monopolistic position of ASML.
  • Technological shift in memory chips: Manufacturers of DRAM memory are transitioning to more advanced nodes (specifically, the move to 1c). This shift necessitates a greater intensity in the use of ASML’s extreme ultraviolet lithography (EUV) systems.

The analysts consider an anticipated ~15% decline in demand from China to be manageable, as the global AI boom is expected to more than compensate for this dip.

Attention now turns to Friday, when US markets reopen after the Thanksgiving holiday. Should American investors join the rally, the assault on the €1,000 mark could quickly become a reality. The next fundamental test will arrive with the Q4 results, where order intake from major clients like TSMC and Intel must confirm this bullish thesis.

Ad

ASML Stock: Buy or Sell?! New ASML Analysis from February 7 delivers the answer:

The latest ASML figures speak for themselves: Urgent action needed for ASML investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

ASML: Buy or sell? Read more here...

Tags: ASML
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Riley Exploration Permian Stock
Analysis

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

February 7, 2026
Next Post
Teva Stock

Teva's Ascent Faces Mounting Skepticism

Fair Isaac Stock

Fair Isaac Shares: A Market Divided by Extreme Views

Lear Stock

Lear Shares: Institutional Buying Surge Meets Cautious Market Sentiment

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com